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1. Introduction 
Niemann-Pick disease is inherited in at least five 
different phenotypes [l] all of which exhibit degrees 
of sphingomyelin accumulation, particularly in the 
reticuloendothelial system. The diseases differ with 
respect to age of onset, degree of neurological involve- 
ment and clinical course of the disorder. In Niemann- 
Pick diseases types A and B, where the lipidosis is most 
severe, sphingomyelinase activity is profoundly deficient. 
However, in types C, D and E disease, sphingomyelinase 
activity is normal [ 1,2] or only partially reduced [2,3]; 
the biochemical basis for these conditions has yet to 
be firmly established. Recently, Callahan et al. [4] 
have indicated that a specific sphingomyelinase compo- 
nent, identifiable by isoelectric focusing, is deficient 
in Niemann-Pick type C (NPC) liver and brain [ 51 and 
in Niemann-Pick type E fibroblasts [6]. These authors 
did not study NPC fibroblasts but suggested that these 
might also be deficient in this sphingomyelinase 
component. 
Recent work [7] has indicated that fibroblast 
sphingomyelinase probably exists in a bound state but 
that the various enzyme components may be separated 
by isoelectric focusing in the presence of Triton X-l 00. 
This technique has been applied to the separation of 
sphingomyelinases in NPC fibroblasts in order to 
identify any missing component. The resulting enzyme 
profile indicated that NPC cells were profoundly 
deficient in two cathodic forms of sphingomyelinase. 
2. Materials and methods 
[(Me-14C)-choline]sphingomyelin was obtained from 
the Radiochemical Centre, Amersham (UK); Amphol- 
North-Holland Publishing Company - Amsterdam 
ine from LKB Produkter AB (Sweden); sodium cholate 
from Sigma Chemical Co. Ltd. (USA) and purified 
Triton X-100, bovine sphingomyelin and 4-methyl- 
umbelliferyl2-acetamide-deoxy-/3-D-glucopyranoside 
from Koch Light Labs. (UK). 
2.1. Cultured skin fibroblasts 
Niemann-Pick type A (NPA) fibroblasts were 
kindly provided by Dr A. D. Patrick (London) and 
Niemann-Pick type C fibroblasts (GM-l 10) by the 
Human Genetic Mutant Cell Repository (New Jersey, 
USA). Methods of cell culture and enzyme extrac- 
tion, into glycine, for isoelectric focusing have been 
described elsewhere [7]. Sodium cholate (5 mg/ml) 
extracts of cell pellets were prepared by four cycles 
of freeze-thawing (in liquid N,), leaving for 30 min at 
4°C and the 1000 X g X 10 min supernatant (l-2 mg 
protein/ml) being used for assay. 
2.2. Enzyme assay 
Sphingomyelinase activity was determined as de- 
scribed [7,8]. The assay mixture contained enzyme extrac 
or column eluate (50 ~1 or 100 /..Q, 250 pg sodium 
cholate, 68 nmol [‘4C]sphingomyelin (40 000 cpm) 
and 20 pmol acetate buffer, pH 5.0, in a final volume 
of 0.2 ml. Incubation (3 h at 37°C) was stopped with 
cold water (0.9 ml), 10% (w/v) bovine serum albumin 
(0.1 ml) and 50% (w/v) trichloroacetic acid (0.2 ml). 
Released [‘4C]phosphorycboline was counted in Bray’s 
scintillation mixture. 
For Km determination, a fixed sphingomyelin: 
sodium cholate ratio was maintained in the substrate 
mixture. 
Activity of /3-hexosaminidase was determined as 
described [9] and protein measured by the Lowry 
method [lo]. 
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2.3. Isoelectric focusing 100 
Electrofocusing was performed in 10 ml J-tubes 
[7] in the presence of 0.1% (v/v) Triton X-l 00. On 
completion (18 h at 400 V and 4°C) fractions (8 drops, 
about 0.25 ml) were collected and analysed for pH 
(4’C) and enzyme activity. 
3. Results and discussion 
Sphingomyelinase activity of NPC fibroblasts was 
low (table 1) but well above that of NPA fibroblasts. 
The activity fell within the range of values (35-113 
nmol/h/mg protein, mean 73 units) obtained from 
thirthy-six control fibroblasts strains. The low activity 
did not result from incomplete enzyme extraction, 
since 98% of total sphingomyelinase was extracted from 
NPC cells, as compared with 94-99% in the controls 
and 89% in the NPA cells. 
The effect of pH on sphingomyelinase activity is 
shown in fig. 1 a. Optimum activity for control 
fibroblasts was at pH 5.0, whereas for NPC cells, maxi- 
mum activity was at pH 5.5. The plot for NPC cells 
suggests considerable loss of enzyme activity at pH 5.0, 
due to isoelectric precipitation; in the absence of 
Triton most of the remaining sphingomyelinase activity 
of NPC cells would have a pl around 5.0 [7]. In the 
presence of Triton, however, both NPC and control 
fibroblasts exhibited broad pH optima, at pH 5.0 
(fig.lb). At pH 5.0 and in the presence of Triton X-100, 
the apparent Km of NPC fibroblasts was 76 I.IM 
(fig.2) less than half that (179 PM) of control cells. 
The control value agrees well with the previous results 
[ 1 l] obtained in the absence of Triton X-100, when 
an apparentK, of 203 PM was recorded for control tibro- 
blasts and 243 PM for NPA fibroblasts. 
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Fig.1. Effect of pH on fibroblast sphingomyelinase activity of 
cholate xtracts (o control; l NPC), in the absence (a), or 
presence (b) of 0.025% (v/v) Triton X-100. 
Earlier isoelectric focusing studies [ 71 on fibro- 
blast sphingomyelinase had demonstrated at least five 
enzyme peaks. In the present study, where a larger 
Table 1 
Fibroblast sphingomyelinase activities nmoles/h/mg protein 
NPC 41.4 
NPA 0.61 
Control 72.2 
Control 98.3 
Control 98.7 
Fig.2. Lineweaver-Burk plot for sphingomyelinase activity 
of fibroblast extracts (0 control, 64 wg protein; l NPC, 78 pg 
protein). Assay for 2 h at pH 5.0 in the presence of 0.025% 
(v/v) Triton X-100. V = mnoles/h/mg protein X lo-‘, S = mM. 
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Fig.3. Isoelectric focusing profiles of fibroblast sphingomye- 
linase (a), and p-hexosaminidase activities (b).o Control extract, 
1.22 mg protein, sphingomyelinase activity 140 nmoles/h/mg 
protein (83% enzyme extraction); 0 control extract, 1.06 mg 
protein, sphingomyelinase activity 99 nmol/h/mg protein, 
sphingomyelmase activity 69 nmol/h/mg protein (84% extrac- 
tion). 
number of fractions was collected, seven enzyme 
peaks were separated (fig.3a), with PI values of 
8.50, 8.25, 7.75, 7.25, 6.80,6.15 and 4.85. NPC fibro- 
blast extracts contained all seven species but peaks I 
and II (PI 8.50 and 8.25) were considerably reduced 
in enzyme activity, with the result that peak VI now 
represented the major enzyme form in these cells. There 
was no marked increase in activity associated with any 
other sphingomyelinase peaks and the observed 
phenomenon would appear to result from an apparent 
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enzyme defect rather than altered p1 values. Shown in 
fig.3b are the focusing profiles of /I-hexosaminidase 
activity, obtained for reference purpose for each cell 
extract; no defect was apparent in either the hexo- 
saminidase A (pZ 5.25) and hexosaminidase B (~1 
8.37) peaks. 
Properties of pooled peaks I and II were compared 
with those of pooled peaks V and VI, from control 
fibroblasts. Neither when assayed directly (in the 
presence of ampholytes, sucrose and Triton X-100) nor 
following dialysis against 0.1% (v/v) Triton X-l 00 was 
any major difference observed with respect to pH 
optimum Km or heat stability. The pH optima of the 
two fractions were slightly lower (pH 4.0-5.0) than 
that obtained for cholate extracts but like these profiles, 
were considerably flattened. The Km values were, 
however, much reduced being 26 PM and 19 uM before 
dialysis and 17 PM and 12 PM after dialysis, for compo- 
nents I plus II and components V plus VI respectively. 
At 50°C in the presence of 10 mM-acetate buffer, pH 
6.0, and bovine serum albumin (0.1 mg/ml) both 
fractions lost about 65% activity after 1 h; similar 
results were obtained for both NPC and control fibro- 
blast extracts. 
If the metabolic lesion in NPC disease is, like other 
types of this disorder [ 121, expressed in cultured tibro- 
blasts then sphingomyelin storage would be predicted, 
despite the persistence of sphingomyelinase comp.onents 
that are catalytically active in vitro. It may be that 
subtle changes underlie this disorder rather than any 
specific enzyme deficiency. The effect of detergents 
on enzyme activity [ 131. loss of activity during enzyme 
purification [2,14] and different Km values recorded 
for the enzyme would suggest hat other factors might 
control catalytic activity. The physiological significance 
of a low mol. wt activator of sphingomyelinase [ 151 
has yet to be assessed and, like fl-glucocerebrosidase 
[ 161, the presence of certain effecters may be essential 
for full activation. A defect in the structure of inter- 
action in vivo of any of these could underlie the defect 
in NPC disease. 
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